EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allergen‐specific immunotherapy by recombinant Der P1 allergen‐derived peptide‐based vaccine in an allergic mouse model

Soheila Asoudeh Moghanloo iD, Mohsen Forouzanfar iD, Mojtaba Jafarinia iD, Mohammad R Fazlollahi iD, Gholam Ali Kardar iD

Immunity, Inflammation and Disease · 2023

DOI: 10.1002/iid3.878 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Soheila Asoudeh Moghanloo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran. Hauptthemen laut MEDLINE: Allergens, Hypersensitivity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Increased IgE levels have made house dust mite allergens one of the most frequent causes of allergies worldwide. Treatment reduces the IgE antibodies and types two cytokines, namely interleukin‐4 (IL‐4) and IL‐13. Although existing treatments significantly reduce IgE or IL‐4/IL‐13, they are very costly. This study aimed to construct a recombinant protein derived from rDer p1 peptides in the form of an immunotherapy approach and to measure the response of IgE and IgG antibodies.

Methods

The proteins were isolated, purified, and evaluated using the SDS‐PAGE and Bradford test and confirmed by using Western blot. To evaluate immunotherapy efficiency, 24 BALB/C mice were sensitized intraperitoneally with house dust mites (HDM) adsorbed to Aluminum hydroxide (Alum) and randomly divided into four groups of six: control sensitized, HDM extract, rDer p1, and DpTTDp vaccine. To immunization, four groups of random mice were each treated with phosphate‐buffered saline, 100 μg of rDer p1 protein, DpTTDp, or HDM extract, every 3 days. Direct ELISA determined HDM‐specific IgG and IgE subclasses. Data were analyzed in SPSS and Graph pad prism software. Values of p < .05 were considered significant.

Results

After immunization of mice, the rDer P1 and recombinant vaccine like HDM extract increased IgG antibody titer and decreased IgE‐dependent reactivity in allergic mice to rDer P1. Also, the levels of inflammatory IL‐4 and IL‐13 cytokines as allergic stimulants decreased.

Conclusion

The use of present available recombinant proteins is considered a viable, cost‐effective, and long‐term option for providing effective HDM allergy immunotherapy vaccines without side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllergensHypersensitivityAnimalsMiceMice, Inbred BALB CInterleukin-4Interleukin-13Vaccines, SyntheticDesensitization, ImmunologicVaccines, SubunitPeptidesCytokinesImmunoglobulin E

Stichwörter der Autor:innen

IL-13IL-4IgEIgGallergen immunotherapyhouse dust mitepeptide based vaccinerDer p1

Substanzen

AllergensInterleukin-4Interleukin-13Vaccines, SyntheticVaccines, SubunitPeptidesCytokinesImmunoglobulin E

Autor:innen und Institutionen

  • Department of Molecular Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran.
  • Immunology, Asthma and Allergy Research Institute (IAARI), Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Soheila Asoudeh Moghanloo, Mohsen Forouzanfar, Mojtaba Jafarinia, Mohammad R Fazlollahi, Gholam Ali Kardar

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Asoudeh Moghanloo, S., Forouzanfar, M., Jafarinia, M., Fazlollahi, M. R., & Kardar, G. A. (2023). Allergen‐specific immunotherapy by recombinant Der P1 allergen‐derived peptide‐based vaccine in an allergic mouse model. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.878

Vancouver

Asoudeh Moghanloo S, Forouzanfar M, Jafarinia M, Fazlollahi MR, Kardar GA. Allergen‐specific immunotherapy by recombinant Der P1 allergen‐derived peptide‐based vaccine in an allergic mouse model. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.878

BibTeX
@article{AsoudehMoghanloo2023,
  author = {Asoudeh Moghanloo, Soheila and Forouzanfar, Mohsen and Jafarinia, Mojtaba and Fazlollahi, Mohammad R and Kardar, Gholam Ali},
  title = {Allergen‐specific immunotherapy by recombinant Der P1 allergen‐derived peptide‐based vaccine in an allergic mouse model},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  doi = {10.1002/iid3.878}
}
Kostenlos starten →